Tyrosine Kinase Inhibitors in Pediatric Malignancies

By Skolnik Jeffrey   Adamson Peter  

Cancer Investigation, Vol. 25, Iss. 7, 2007-10 ,pp. : 606-612

Informa Healthcare

Access to resources Recommend Favorite

Synthesis of Quinazolines as Tyrosine Kinase Inhibitors

By  

Anti-Cancer Agents in Medicinal Chemistry (Formerly Current Medicinal Chemistry - Anti-Cancer Agents), Vol. 9, Iss. 3, 2009-03 ,pp. : 246-275

Bentham Science Publishers

Access to resources Recommend Favorite

Molecular mechanisms of lungspecific toxicity induced by epidermal growth factor receptor tyrosine kinase inhibitors (Review)

By Sakao Seiichiro   Tatsumi Koichiro  

Oncology Letters, Vol. 4, Iss. 5, 2012-11 ,pp. : 865-867

Spandidos Publications

Access to resources Recommend Favorite

Clinical development of EGFR-tyrosine kinase inhibitors in Japan

By Nakagawa Kazuhiko  

Cancer Chemotherapy and Pharmacology, Vol. 58, Iss. 1, 2006-11 ,pp. : 33-37

Springer Publishing Company

Access to resources Recommend Favorite

Clinical development of EGFR-tyrosine kinase inhibitors in Japan

By Nakagawa Kazuhiko  

Cancer Chemotherapy and Pharmacology, Vol. 58, Iss. 7, 2006-11 ,pp. : 33-37

Springer Publishing Company

Access to resources Recommend Favorite